StockData
Alvotech logo

Alvotech (ALVO) stock

ALVONasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as ALVOW
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 31, 2026Score 3/30
$4.37−0.04 (-0.79%)

Close on Nov 17, 2026Market cap $1.36BP/E 43.7Yield –

Alvotech enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Alvotech's enterprise value was $2.92B on Nov 11, 2026, against $2.56B a year earlier. Over the last 5 years it ranged from $388.89M to $5.06B, with a median of $3.19B.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$2.92B+13.8%
2025Dec 31, 2025$2.57B-45.9%
2024Dec 31, 2024$4.74B+25.4%
2023Dec 29, 2023$3.78B+863.5%
2022Dec 30, 2022$392.29M-56.1%
2021Dec 31, 2021$893.56M–

More Alvotech figures

See a number that looks wrong?